Project Grant 90DPHF0014

Award Date 9/1/24
Completion Date 8/31/29
Dollars Obligated $1.5M
Federal Grant Program
93.433
Assistance Type
Project Grant
Place of Performance
South Carolina, USA
Similar Awards
The Medical University of South Carolina will receive $896,396 through a Project Grant award from the Department of the Army Medical Command. The grant is part of the Military Medical Research and Development program (CFDA 12.420) and will fund research on Targeted Spinal Cord Plasticity for Alleviating SCI-Related Neuropathic Pain from September 30, 2022 through September 29, 2025. Through this award, researchers at The Medical University of South Carolina will investigate medical solutions...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports a 5-year, $2,726,432 research study on co-use of cannabis and prescription opioids among emerging adults in medical settings. The study will enroll emerging adults aged 18-25 who either have no history of cannabis use or have used cannabis in the past month and are prescribed an opioid for acute pain management. Participants will be followed...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $1,360,092 to The Medical University of South Carolina to conduct a study titled "Real-World Assessment of Social Functioning During OUD Treatment: Integrating Reports from Patients and Their Concerned Significant Others." The study aims to examine how affiliative social engagement behaviors, social reward, and social connection...
This federal Project Grant award, with ID R01DA062041, was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The $1,039,420 grant supports a research project titled "Multiplexed Dissection of Neuronal Ensembles in Circuits that Underlie the Facilitation and Disinhibition of Opioid and Alcohol Seeking" at the Medical University of South Carolina (MUSC). The project aims to characterize the transcriptomic profiles...
This $504,554.68 Project Grant award was provided by the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR), a program within the Administration for Community Living, U.S. Department of Health and Human Services. The award will fund a 24-month research project at the University of South Carolina to implement and evaluate an adapted version of the PHOENIX peer mentoring program for individuals with spinal cord injuries in South Carolina. The project...
This $779,969 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to improve perioperative care for patients with opioid use disorder. The grant will fund a 5-year study to prospectively capture patient-reported pain and opioid use among individuals with opioid use disorder undergoing common surgical procedures, and develop a clinical care pathway to optimize perioperative outcomes across a network of...
This Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) is focused on lowering cardiovascular disease (CVD) risk among people with opioid use disorder (OUD). The $189,500 award, effective April 15, 2025 through March 31, 2030, will be used by the University of Pittsburgh to: Examine the relationship between OUD and major adverse cardiovascular events (MACE). 2) Determine barriers and facilitators to CVD prevention among people...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), part of the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, will provide $545,612 to The Ohio State University to conduct research aimed at reducing adipose tissue dysfunction and metabolic complications after spinal cord injury (SCI). The key objectives are to evaluate the extent to which modulating the A2D1 subunit of voltage-gated...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $9,237,770 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to The Washington University to conduct the "IMPETUS: Integrated Mechanisms, Phenotypes, and Translational Underpinnings of Chronic Pain After Surgery" research project. The goal is to gain integrated mechanistic insights into peripheral and central biological processes that contribute to chronic postsurgical pain...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $722,876 to New York University School of Medicine to conduct a study characterizing complex opioid use disorder (OUD) care trajectories and outcomes following acute service utilization. The study aims to: 1) characterize real-world trajectories of OUD treatment in the year following hospital encounters among treatment-naive individuals and...

The Medical University of South Carolina (MUSC) received a $1,499,775 Project Grant award from the National Institute on Disability, Independent Living, and Rehabilitation Research (CFDA 93.433) to conduct a longitudinal study on opioid use, misuse, and co-use of other substances among individuals with traumatic spinal cord injury (SCI). The 5-year study aims to: (1) describe the prevalence and changes in prescription opioid use, misuse, and co-use of other substances; (2) identify person and environmental risk factors; and (3) examine the relationships between changes in use and outcomes in health, participation, and employment. The project will involve a 5-year follow-up of 1,396 existing participants and enrollment of 1,000 new participants from population-based registries. Qualitative focus groups with 40 participants will also explore perceived benefits and drawbacks of prescription opioids in self-managing pain and other secondary conditions. The anticipated outcomes include new knowledge to guide policy, clinical practice, prevention, and self-management strategies to reduce the risks of opioid use, misuse, co-use, overdose, and SCI-related secondary conditions.

Generated 8/5/25, 6:00 AM